Chembio Diagnostics, Inc.

CEMIDelisted Apr 27, 2023

Industry: Pharmaceutical Preparations
SEC CIK: 0001092662

SEC filings (opens in a new tab)

Chembio Diagnostics, Inc. was delisted on Apr 27, 2023; its insiders filed their last Form 4 on May 2, 2023; 30 institutions reported holding it in 13F filings for Q1 2023, worth $1.36M in total; no superinvestor held it.

Q4 2021 vs. Q3 2021

How the institutions holding Chembio Diagnostics, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021 All holders in Q3 2021

13F holders of CEMI: Q3 2021 compared with Q4 2021
Measure	Q3 2021	Q4 2021	Change
Holders	47	43	−4
Shares	3.97M	4.02M	+49.9K (+1.3%)
Value	$9.94M	$4.58M	−$5.35M (−53.9%)

New holders (9)

Institutions that held Chembio Diagnostics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to CEMI in Q4 2021
Institution	Shares	Value	% of portfolio
Engineers Gate Manager LP	135,235	$154.0K	0.01%
Goldman Sachs Group Inc	92,168	$105.0K	0.00%
Two Sigma Securities, LLC	35,905	$41.0K	0.01%
XTX Topco Ltd	19,529	$22.0K	0.01%
HRT Financial LP	18,957	$21.0K	0.00%
PEAK6 Investments LLC	16,083	$18.0K	0.00%
UBS Group AG	10,294	$12.0K	0.00%
Federated Hermes, Inc.	91	$1.00K	0.00%
Bank of America Corp	153	$0	0.00%

Sold out (13)

Institutions that held Chembio Diagnostics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of CEMI in Q4 2021
Institution	Shares, Q3 2021	Value, Q3 2021
Segall Bryant & Hamill, LLC	350,659	$877.0K
Dimensional Fund Advisors LP	54,662	$137.0K
Ameriprise Financial Inc	52,625	$132.0K
Gagnon Securities LLC	47,793	$119.0K
Squarepoint Ops LLC	38,608	$97.0K
Jump Financial, LLC	37,900	$95.0K
Sigma Planning Corp	19,300	$48.0K
NEXT Financial Group, Inc	6,000	$15.0K
Royal Bank of Canada	3,019	$8.00K
Barclays PLC	2,359	$6.00K
Tower Research Capital LLC (TRC)	896	$2.00K
Captrust Financial Advisors	500	$1.00K
Focused Wealth Management, Inc	375	$1.00K